Anli Yang

2.4k total citations
71 papers, 1.6k citations indexed

About

Anli Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anli Yang has authored 71 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 28 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Anli Yang's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (10 papers). Anli Yang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (10 papers). Anli Yang collaborates with scholars based in China, United States and Hong Kong. Anli Yang's co-authors include Yutian Zou, Shaoquan Zheng, Hailin Tang, Weikai Xiao, Xiaoming Xie, Xiaoming Xie, Xinhua Xie, Yanan Kong, Jie‐Ying Liang and Feng Cai and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Anli Yang

66 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anli Yang China 24 917 780 381 325 121 71 1.6k
Liangfang Shen China 24 946 1.0× 598 0.8× 390 1.0× 202 0.6× 79 0.7× 77 1.5k
JiHoon Kang South Korea 21 642 0.7× 476 0.6× 493 1.3× 275 0.8× 113 0.9× 63 1.4k
Mikael Johansson Sweden 20 826 0.9× 619 0.8× 483 1.3× 449 1.4× 107 0.9× 44 1.8k
Qin Dang China 19 911 1.0× 678 0.9× 442 1.2× 567 1.7× 87 0.7× 51 1.7k
Wenjin Yin China 23 781 0.9× 739 0.9× 647 1.7× 314 1.0× 55 0.5× 90 1.6k
Robert Lemos United States 15 878 1.0× 531 0.7× 438 1.1× 207 0.6× 107 0.9× 20 1.4k
Jessica A. Bertout United States 8 1.1k 1.2× 1.3k 1.7× 400 1.0× 265 0.8× 241 2.0× 11 2.0k
Niamh Lynam‐Lennon Ireland 17 768 0.8× 588 0.8× 307 0.8× 214 0.7× 66 0.5× 43 1.3k
Yang Xia China 28 1.3k 1.4× 1.1k 1.4× 175 0.5× 220 0.7× 98 0.8× 58 1.7k
Bin Shi China 10 1.2k 1.3× 606 0.8× 852 2.2× 271 0.8× 91 0.8× 16 2.1k

Countries citing papers authored by Anli Yang

Since Specialization
Citations

This map shows the geographic impact of Anli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anli Yang more than expected).

Fields of papers citing papers by Anli Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anli Yang. The network helps show where Anli Yang may publish in the future.

Co-authorship network of co-authors of Anli Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Anli Yang. A scholar is included among the top collaborators of Anli Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anli Yang. Anli Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Anli, et al.. (2025). Porous Organic Cages with Aggregation‐Induced Emission Property for Anti‐counterfeiting Ink Bioimaging. Energy & environment materials. 8(4). 1 indexed citations
2.
Zhao, Jiayi, et al.. (2024). MLLT6/ATF2 Axis Restrains Breast Cancer Progression by Driving DDIT3/4 Expression. Molecular Cancer Research. 22(9). 796–811. 2 indexed citations
3.
Xie, Jindong, Anli Yang, Qianwen Liu, et al.. (2024). Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target. Cell Proliferation. 57(11). e13697–e13697. 28 indexed citations
4.
Zou, Yutian, Anli Yang, Bo Chen, et al.. (2024). crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer. Drug Resistance Updates. 77. 101126–101126. 42 indexed citations
5.
Lu, Yongkui, Lixia Li, Meiting Chen, et al.. (2024). Eribulin plus carboplatin combination for HER2-negative metastatic breast cancer: a multicenter, real-world cohort study. BMC Cancer. 24(1). 1214–1214.
6.
Liu, Yan, Yupu Wang, Kaixuan Li, et al.. (2024). Analysis and Characterization Techniques for Wide Band Gap Semiconductor Materials. 1–5.
7.
Ou, Xueqi, Yeru Tan, Guanfeng Gao, et al.. (2023). Development and Verification of a Prognostic Stemness-Related Gene Signature in Triple-Negative Breast Cancer. Journal of Oncology. 2023. 1–13. 1 indexed citations
8.
Dong, Fan, Anli Yang, & Dian Ouyang. (2023). Retroauricular Single-Site Endoscopic Thyroidectomy—A Balanced Endoscopic Approach for Thyroid Excision. JAMA Surgery. 158(5). 548–548. 3 indexed citations
9.
Ni, Ming, Lanlan Zhou, You Lü, et al.. (2023). 63P Efficacy and safety of eribulin plus carboplatin combination for HER2-negative metastatic breast cancer. Annals of Oncology. 34. S1490–S1490.
10.
Yang, Anli, Weikai Xiao, Shaoquan Zheng, et al.. (2021). Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer. Cancer Control. 28. 1149432682–1149432682. 5 indexed citations
11.
Chaudhary, Ketul R., Yupu Deng, Anli Yang, Nicholas D Cober, & Duncan J. Stewart. (2021). Penetrance of Severe Pulmonary Arterial Hypertension in Response to Vascular Endothelial Growth Factor Receptor 2 Blockade in a Genetically Prone Rat Model Is Reduced by Female Sex. Journal of the American Heart Association. 10(15). e019488–e019488. 14 indexed citations
12.
Bauer, Nicholas C., Anli Yang, Xin Wang, et al.. (2021). A cross-nearest neighbor/Monte Carlo algorithm for single-molecule localization microscopy defines interactions between p53, Mdm2, and MEG3. Journal of Biological Chemistry. 296. 100540–100540. 2 indexed citations
13.
Wei, Xiaoli, Qianwen Liu, Furong Liu, et al.. (2021). The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer. OncoImmunology. 10(1). 1938381–1938381. 17 indexed citations
14.
15.
Zheng, Shaoquan, Yutian Zou, Xinhua Xie, et al.. (2020). Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple‐negative breast cancer. International Journal of Cancer. 147(2). 542–553. 43 indexed citations
16.
An, Xin, Xi Lin, Anli Yang, et al.. (2020). Cavin3 Suppresses Breast Cancer Metastasis via Inhibiting AKT Pathway. Frontiers in Pharmacology. 11. 1228–1228. 3 indexed citations
17.
Ye, Feng, Ping Yu, Na Li, et al.. (2020). Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies. The Breast. 51. 11–20. 17 indexed citations
18.
Zou, Yutian, Shaoquan Zheng, Xinpei Deng, et al.. (2019). The Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis. Biomolecules. 9(9). 429–429. 100 indexed citations
19.
Mao, Yanfei, Xin Wang, Anli Yang, et al.. (2019). Meg3-DMR, not the Meg3 gene, regulates imprinting of the Dlk1-Dio3 locus. Developmental Biology. 455(1). 10–18. 10 indexed citations
20.
Xiao, Weikai, Shaoquan Zheng, Anli Yang, et al.. (2018). Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study. Cancer Management and Research. Volume 10. 5329–5338. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liangfang Shen Breakdown of academic impact, for papers by JiHoon Kang Breakdown of academic impact, for papers by Mikael Johansson Breakdown of academic impact, for papers by Qin Dang Breakdown of academic impact, for papers by Wenjin Yin Breakdown of academic impact, for papers by Robert Lemos Breakdown of academic impact, for papers by Jessica A. Bertout Breakdown of academic impact, for papers by Niamh Lynam‐Lennon Breakdown of academic impact, for papers by Yang Xia Breakdown of academic impact, for papers by Bin Shi
Rankless by CCL
2026